Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Genistein
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Humanetics
Deal Size : Undisclosed
Deal Type : Acquisition
Humanetics Acquires Manufacturing Assets for Radioprotectant
Details : Included in the acquisition are patents, trademarks, trade secret manufacturing processes, analytical methods, regulatory filings, and a large number of nonclinical and clinical safety studies.
Product Name : BIO 300
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 19, 2020
Lead Product(s) : Genistein
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Humanetics
Deal Size : Undisclosed
Deal Type : Acquisition